Login to Your Account



Centocor's Ustekinumab Bests Enbrel in Phase III Psoriasis Trial

By Staff Reports


Friday, September 19, 2008
No Abstract

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription